Shares of First Wave BioPharma Inc. soared 71.7% in active premarket trading Thursday, after the biopharmaceutical company announced an agreement to license.
Capital Market Strategies LLC bought a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 2,639 shares of the financial services provider’s stock, valued at approximately $335,000. Other hedge funds also recently […]
Atomi Financial Group Inc. purchased a new position in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) during the 1st quarter, HoldingsChannel reports. The firm purchased 3,887 shares of the financial services provider’s stock, valued at approximately $502,000. Several other hedge funds and other institutional investors have also recently bought and sold shares of IBB. Moneta […]
Williams Jones Wealth Management LLC. lifted its stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 2.0% during the first quarter, HoldingsChannel reports. The firm owned 108,631 shares of the financial services provider’s stock after purchasing an additional 2,181 shares during the period. Williams Jones Wealth Management LLC.’s holdings in iShares Biotechnology ETF were […]
Crestwood Advisors Group LLC reduced its position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 4.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 23,527 shares of the financial services provider’s stock after selling 1,040 shares during the […]